Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
76
BNT Quote, Financials, Valuation and Earnings
Last price:
$67.98
Seasonality move
:
4.33%
Day range:
$63.37 - $65.63
52-week range:
$42.31 - $65.63
Dividend yield:
0%
P/E ratio:
29.88x
P/S ratio:
0.86x
P/B ratio:
1.30x
Volume:
22.4K
Avg. volume:
10.3K
1-year change:
39.22%
Market cap:
$15.9B
Revenue:
$14.3B
EPS (TTM):
$2.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $514M | $1B | $4.4B | $7B | $14.3B | |
| Revenue Growth (YoY) | 34.56% | 100.97% | 323.04% | 59.11% | 106.2% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6M | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | $224M | $413M | $781M | |
| Operating Expenses | $6M | $35M | $411M | $777M | $1.4B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $1M | $104M | $249M | $362M | |
| EBT. Incl. Unusual Items | $2M | -$113M | $532M | $814M | $1.2B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | -$1M | $31M | $17M | -$34M | |
| Net Income to Company | $1M | -$112M | $501M | $797M | $1.2B | |
| Minority Interest in Earnings | -- | -- | -$2M | -$1M | -$33M | |
| Net Income to Common Excl Extra Items | $1M | -$112M | $499M | $796M | $1.2B | |
| Basic EPS (Cont. Ops) | $0.04 | -$4.92 | $13.75 | $10.51 | $8.69 | |
| Diluted EPS (Cont. Ops) | $0.04 | -$4.92 | $13.75 | $10.51 | $8.69 | |
| Weighted Average Basic Share | $27.8M | $19.9M | $30.9M | $64.2M | $126M | |
| Weighted Average Diluted Share | $27.8M | $19.9M | $30.9M | $64.2M | $126M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $2M | -$112M | $636M | $1.1B | $1.6B | |
| Revenue (Reported) | $514M | $1B | $4.4B | $7B | $14.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $2M | -$112M | $636M | $1.1B | $1.6B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$60M | $278M | $1.2B | $2.5B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | 332.73% | 110.22% | -4.39% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | $112M | $179M | |
| Operating Expenses | $3M | $17M | $176M | $233M | $382M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $5M | $60M | $72M | $73M | |
| EBT. Incl. Unusual Items | $4M | $161M | -$104M | $362M | -$369M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | $5M | -$11M | $25M | -$87M | |
| Net Income to Company | $3M | $156M | -$93M | $337M | -$282M | |
| Minority Interest in Earnings | -- | -- | -$5M | -$2M | -$44M | |
| Net Income to Common Excl Extra Items | $3M | $156M | -$98M | $335M | -$326M | |
| Basic EPS (Cont. Ops) | $0.11 | $4.53 | -$1.89 | $2.98 | -$1.64 | |
| Diluted EPS (Cont. Ops) | $0.11 | $4.53 | -$1.89 | $2.98 | -$1.64 | |
| Weighted Average Basic Share | $27.8M | $34.4M | $51.8M | $102.1M | $201.1M | |
| Weighted Average Diluted Share | $27.8M | $34.4M | $51.8M | $102.1M | $201.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4M | $166M | -$44M | $434M | -$296M | |
| Revenue (Reported) | -$60M | $278M | $1.2B | $2.5B | $2.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4M | $166M | -$44M | $434M | -$296M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $464M | $1.4B | $5.3B | $8.3B | $14.3B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | $224M | $428M | $848M | |
| Operating Expenses | -- | $49M | $570M | $836M | $1.5B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $6M | $159M | $261M | $363M | |
| EBT. Incl. Unusual Items | $6M | $45M | $267M | $1.3B | $482M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2M | $4M | $15M | $53M | -$146M | |
| Net Income to Company | $4.1M | $41M | $252M | $1.2B | $628M | |
| Minority Interest in Earnings | -- | -- | -$7M | $2M | -$75M | |
| Net Income to Common Excl Extra Items | $4M | $41M | $245M | $1.2B | $553M | |
| Basic EPS (Cont. Ops) | $0.14 | $2.93 | $4.48 | $13.23 | $2.20 | |
| Diluted EPS (Cont. Ops) | $0.14 | $2.93 | $4.48 | $13.23 | $2.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $6M | $51M | $426M | $1.5B | $845M | |
| Revenue (Reported) | $464M | $1.4B | $5.3B | $8.3B | $14.3B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $6M | $51M | $426M | $1.5B | $845M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -$60M | $278M | $1.2B | $2.5B | $2.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | $112M | $179M | |
| Operating Expenses | $3M | $17M | $176M | $233M | $382M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $5M | $60M | $72M | $73M | |
| EBT. Incl. Unusual Items | $4M | $161M | -$104M | $362M | -$369M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $1M | $5M | -$11M | $25M | -$87M | |
| Net Income to Company | $3M | $156M | -$93M | $337M | -$282M | |
| Minority Interest in Earnings | -- | -- | -$5M | -$2M | -$44M | |
| Net Income to Common Excl Extra Items | $3M | $156M | -$98M | $335M | -$326M | |
| Basic EPS (Cont. Ops) | $0.11 | $4.53 | -$1.89 | $2.98 | -$1.64 | |
| Diluted EPS (Cont. Ops) | $0.11 | $4.53 | -$1.89 | $2.98 | -$1.64 | |
| Weighted Average Basic Share | $27.8M | $34.4M | $51.8M | $102.1M | $201.1M | |
| Weighted Average Diluted Share | $27.8M | $34.4M | $51.8M | $102.1M | $201.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $4M | $166M | -$44M | $434M | -$296M | |
| Revenue (Reported) | -$60M | $278M | $1.2B | $2.5B | $2.4B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $4M | $166M | -$44M | $434M | -$296M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $35M | $393M | $2.1B | $4.3B | $12.2B | |
| Short Term Investments | -- | -- | -- | $21.9B | $16.8B | |
| Accounts Receivable, Net | -- | -- | $483M | $1.1B | $1.2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $44M | $549M | $2.6B | $27.3B | $30.2B | |
| Property Plant And Equipment | $2M | $2M | $194M | $294M | $272M | |
| Long-Term Investments | $1.2B | $4.5B | $30.3B | $25.6B | $62.1B | |
| Goodwill | -- | -- | $121M | $121M | $783M | |
| Other Intangibles | -- | $3M | $52M | $235M | $1.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.4B | $11.5B | $43.5B | $61.6B | $140B | |
| Accounts Payable | $4M | $132M | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $6M | $681M | $241M | $564M | $684M | |
| Long-Term Debt | -- | $693M | $3.8B | $3.7B | $4.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.4B | $10.1B | $39.2B | $52.8B | $126.9B | |
| Common Stock | -- | $1.4B | $4.5B | $7.9B | $10B | |
| Other Common Equity Adj | -- | -- | -$523M | -$120M | $204M | |
| Common Equity | $83M | $1.4B | $1.7B | $6B | $12.2B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $8M | $146M | $850M | |
| Total Equity | $83M | $1.4B | $4.3B | $8.8B | $13.1B | |
| Total Liabilities and Equity | $1.4B | $11.5B | $43.5B | $61.6B | $140B | |
| Cash and Short Terms | $35M | $393M | $2.1B | $26.2B | $29B | |
| Total Debt | -- | $693M | $3.8B | $3.7B | $4.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $80.1M | $323M | $2.4B | $2.8B | $8.3B | |
| Short Term Investments | -- | -- | $19.2B | -- | $22.8B | |
| Accounts Receivable, Net | $2.3M | $69M | $1.1B | $4.2B | $1.2B | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $92.5M | $465M | $22.6B | $7B | $32.2B | |
| Property Plant And Equipment | $2.1M | $2M | $193M | -- | $269M | |
| Long-Term Investments | $1.1B | $5.4B | $20.4B | -- | $67.7B | |
| Goodwill | -- | -- | -- | -- | $783M | |
| Other Intangibles | -- | $1M | -- | -- | $1.7B | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $1.4B | $11.6B | $45B | $63.1B | $141.6B | |
| Accounts Payable | $4.9M | $104M | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $5M | $602M | $247M | $555M | $692M | |
| Long-Term Debt | -- | $751M | $3.7B | $3.7B | $4.5B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $1.3B | $10.1B | $40.5B | $53.9B | $128.6B | |
| Common Stock | $102.6M | $1.4B | $4.4B | $9B | $10B | |
| Other Common Equity Adj | $4.5M | -- | -- | -- | $548M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $9M | $145M | $771M | |
| Total Equity | $111.9M | $1.4B | $4.4B | $9.2B | $13B | |
| Total Liabilities and Equity | $1.4B | $11.6B | $45B | $63.1B | $141.6B | |
| Cash and Short Terms | $80.1M | $323M | $21.6B | $2.8B | $31B | |
| Total Debt | -- | $751M | $3.7B | $3.7B | $4.5B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $1M | -$112M | $501M | $797M | $1.2B | |
| Depreciation & Amoritzation | -- | -- | $13M | $50M | $206M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | $22M | $50M | $186M | $1.2B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $399M | $1.7B | $644M | $1.5B | $4.6B | |
| Capital Expenditures | $1M | $1M | $24M | $135M | $40M | |
| Cash Acquisitions | -- | -- | -$4.3B | -$274M | $10.8B | |
| Cash From Investing | -$385M | -$4B | -$4.9B | -$1.8B | $1.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $1.8B | $5.5B | $2.9B | $6.8B | |
| Long-Term Debt Repaid | -- | -$582M | -$3B | -$3B | -$6.9B | |
| Repurchase of Common Stock | -- | -$8M | -$6M | -$5M | -$14M | |
| Other Financing Activities | -- | -- | $496M | $2.6B | $2.1B | |
| Cash From Financing | $13M | $2.6B | $6B | $2.5B | $1.9B | |
| Beginning Cash (CF) | $13M | $35M | $393M | $2.1B | $4.3B | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $27M | $357M | $1.8B | $2.2B | $7.9B | |
| Ending Cash (CF) | $35M | $393M | $2.1B | $4.3B | $12.2B | |
| Levered Free Cash Flow | $398M | $1.7B | $620M | $1.4B | $4.5B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3M | $156M | -$93M | $337M | -$282M | |
| Depreciation & Amoritzation | -- | $3M | -$15M | $36M | $64M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | $16M | $16M | -$32M | $350M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23M | $77M | $198M | $232M | $529M | |
| Capital Expenditures | -- | -- | $26M | $16M | $7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $40M | -$269M | -$74M | -$2.3B | -$5.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $203M | $338M | $533M | $527M | |
| Long-Term Debt Repaid | -- | -$79M | -$450M | -$557M | -$556M | |
| Repurchase of Common Stock | -- | -$2M | -- | -$3M | -$4M | |
| Other Financing Activities | -- | -- | $182M | $327M | $1.1B | |
| Cash From Financing | $25M | $122M | $86M | $333M | $1.1B | |
| Beginning Cash (CF) | $35M | $393M | $2.1B | $4.3B | $12.2B | |
| Foreign Exchange Rate Adjustment | $3M | -- | -$1M | -$6M | $4M | |
| Additions / Reductions | $42M | -$70M | $210M | -$1.7B | -$4B | |
| Ending Cash (CF) | $80M | $323M | $2.4B | $2.6B | $8.3B | |
| Levered Free Cash Flow | -$23M | $77M | $172M | $216M | $522M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.1M | $41M | $252M | $1.2B | $628M | |
| Depreciation & Amoritzation | -- | $3M | -$5M | $101M | $234M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | $38M | $50M | $138M | $1.6B | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $354.8M | $1.8B | $765M | $1.5B | $4.9B | |
| Capital Expenditures | $987K | $1M | $50M | $125M | $31M | |
| Cash Acquisitions | -- | -- | -$4.3B | -$274M | $10.8B | |
| Cash From Investing | -$329.2M | -$4.3B | -$4.7B | -$4B | -$1.8B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $2B | $5.6B | $3.1B | $6.8B | |
| Long-Term Debt Repaid | $62K | -$661M | -$3.3B | -$3.1B | -$6.9B | |
| Repurchase of Common Stock | -- | -- | -$4M | -$8M | -$15M | |
| Other Financing Activities | -- | -- | $678M | $2.8B | $2.8B | |
| Cash From Financing | $38.1M | $2.7B | $6B | $2.7B | $2.6B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $63.7M | $245M | $2B | $225M | $5.7B | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $353.9M | $1.8B | $715M | $1.4B | $4.8B | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $3M | $156M | -$93M | $337M | -$282M | |
| Depreciation & Amoritzation | -- | $3M | -$15M | $36M | $64M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | $16M | $16M | -$32M | $350M | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -$23M | $77M | $198M | $232M | $529M | |
| Capital Expenditures | -- | -- | $26M | $16M | $7M | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $40M | -$269M | -$74M | -$2.3B | -$5.6B | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $203M | $338M | $533M | $527M | |
| Long-Term Debt Repaid | -- | -$79M | -$450M | -$557M | -$556M | |
| Repurchase of Common Stock | -- | -$2M | -- | -$3M | -$4M | |
| Other Financing Activities | -- | -- | $182M | $327M | $1.1B | |
| Cash From Financing | $25M | $122M | $86M | $333M | $1.1B | |
| Beginning Cash (CF) | $35M | $393M | $2.1B | $4.3B | $12.2B | |
| Foreign Exchange Rate Adjustment | $3M | -- | -$1M | -$6M | $4M | |
| Additions / Reductions | $42M | -$70M | $210M | -$1.7B | -$4B | |
| Ending Cash (CF) | $80M | $323M | $2.4B | $2.6B | $8.3B | |
| Levered Free Cash Flow | -$23M | $77M | $172M | $216M | $522M | |
Get BNT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BNT
Sector
P/E ratio
29.88x
12.18x
PEG ratio
0.02x
0.40x
P/B ratio
1.30x
1.10x
Price / LTM sales
0.86x
2.66x
Growth Metrics
BNT
Sector
Revenue growth
-4.39%
5.1%
Earnings growth
-26.33%
2.61%
Revenue (5-year growth)
106.48%
5.17%
Earnings forecast
--
$0.61
Profitability
BNT
Sector
Profitability FY 2025
--
$138.7M
Return on invested capital
3.32%
5.2%
Return on assets
0.45%
0.97%
Return on equity
4.61%
9.24%
Earnings Date
Last Earnings Date
May
8
Next Earnings Date
Aug
8
Estimated Next Earnings Date
Aug
7
Balance Sheet
BNT
Sector
Total cash
$31B
$452M
Short term investments
$16.8B
$220.9M
Total assets
$140B
$3.8B
Long term debt
$4.5B
$280.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
